domperidone has been researched along with ergovaline in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Birrenkott, GP; Cross, DL; Grimes, LW; Strickland, JR | 1 |
| Boling, JA; Matthews, JC; Miles, ED; Strickland, JR; Xue, Y | 1 |
| Bond, KG; Cross, DL; Donnell, RL; Farr, H; Longhofer, SL; Prado, JC; Reinemeyer, CR | 1 |
1 trial(s) available for domperidone and ergovaline
| Article | Year |
|---|---|
Efficacy of domperidone gel in an induced model of fescue toxicosis in periparturient mares.
Topics: Animals; Domperidone; Ergotamines; Ergotism; Female; Festuca; Gels; Gestational Age; Horse Diseases; Horses; Lactation; Lolium; Neotyphodium; Parturition; Pilot Projects; Placebos; Poaceae; Pregnancy; Pregnancy Complications; Treatment Outcome | 2012 |
2 other study(ies) available for domperidone and ergovaline
| Article | Year |
|---|---|
Effect of ergovaline, loline, and dopamine antagonists on rat pituitary cell prolactin release in vitro.
Topics: Alkaloids; Animals; Cells, Cultured; Domperidone; Dopamine; Dopamine Antagonists; Dose-Response Relationship, Drug; Ergolines; Ergotamines; Male; Pituitary Gland; Prolactin; Radioimmunoassay; Rats; Rats, Wistar; Sulpiride; Vasoconstrictor Agents | 1994 |
Ergopeptines bromocriptine and ergovaline and the dopamine type-2 receptor inhibitor domperidone inhibit bovine equilibrative nucleoside transporter 1-like activity.
Topics: Animals; Bromocriptine; Cattle; Cell Line; Domperidone; Dopamine Agonists; Dopamine Antagonists; Equilibrative Nucleoside Transporter 1; Ergotamines; Gene Expression; Kidney; Receptors, Dopamine; Uridine; Vasoconstrictor Agents | 2011 |